Flow Neuroscience develops a portable transcranial direct current stimulation (tDCS) headset designed to treat depression through non-invasive brain stimulation. The company’s system targets the prefrontal cortex using low-intensity electrical currents delivered via a wearable device. Its platform is intended for at-home use, enabling patients to access therapy without medication. Flow Neuroscience positions its technology within regulated clinical treatment pathways rather than general wellness.

The technology applies controlled direct current stimulation to modulate neural activity in brain regions associated with mood regulation. Treatment protocols are delivered through structured sessions and supported by companion software that guides usage and tracks adherence. This approach does not involve neural recording, focusing instead on therapeutic stimulation based on established neuromodulation principles. The headset is designed for repeated, supervised use under prescribed protocols.

Flow Neuroscience targets individuals diagnosed with depression who are seeking non-pharmacological treatment options. The platform is intended to complement or provide alternatives to medication and traditional therapy within clinical care frameworks. Its focus reflects growing adoption of home-based neuromodulation systems aimed at increasing access to mental health treatment.